Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 261

1.

Hepatocellular carcinoma: response to TACE assessed with semiautomated volumetric and functional analysis of diffusion-weighted and contrast-enhanced MR imaging data.

Bonekamp S, Jolepalem P, Lazo M, Gulsun MA, Kiraly AP, Kamel IR.

Radiology. 2011 Sep;260(3):752-61. doi: 10.1148/radiol.11102330. Epub 2011 Jul 19.

PMID:
21771960
2.

Islet cell liver metastases: assessment of volumetric early response with functional MR imaging after transarterial chemoembolization.

Li Z, Bonekamp S, Halappa VG, Corona-Villalobos CP, Pawlik T, Bhagat N, Reyes D, Lai H, Geschwind JF, Kamel IR.

Radiology. 2012 Jul;264(1):97-109. doi: 10.1148/radiol.12112161. Epub 2012 May 24.

PMID:
22627602
3.

Radiologic-pathologic analysis of contrast-enhanced and diffusion-weighted MR imaging in patients with HCC after TACE: diagnostic accuracy of 3D quantitative image analysis.

Chapiro J, Wood LD, Lin M, Duran R, Cornish T, Lesage D, Charu V, Schernthaner R, Wang Z, Tacher V, Savic LJ, Kamel IR, Geschwind JF.

Radiology. 2014 Dec;273(3):746-58. doi: 10.1148/radiol.14140033. Epub 2014 Jul 15.

4.

Assessment of metastatic breast cancer response to chemoembolization with contrast agent enhanced and diffusion-weighted MR imaging.

Buijs M, Kamel IR, Vossen JA, Georgiades CS, Hong K, Geschwind JF.

J Vasc Interv Radiol. 2007 Aug;18(8):957-63.

PMID:
17675611
5.

The role of functional MR imaging in the assessment of tumor response after chemoembolization in patients with hepatocellular carcinoma.

Kamel IR, Bluemke DA, Eng J, Liapi E, Messersmith W, Reyes DK, Geschwind JF.

J Vasc Interv Radiol. 2006 Mar;17(3):505-12.

PMID:
16567675
6.

Intravoxel incoherent motion diffusion-weighted MR imaging of hepatocellular carcinoma: correlation with enhancement degree and histologic grade.

Woo S, Lee JM, Yoon JH, Joo I, Han JK, Choi BI.

Radiology. 2014 Mar;270(3):758-67. doi: 10.1148/radiol.13130444. Epub 2013 Oct 30.

PMID:
24475811
7.

Evaluating local hepatocellular carcinoma recurrence post-transcatheter arterial chemoembolization: is diffusion-weighted MRI reliable as an indicator?

Goshima S, Kanematsu M, Kondo H, Yokoyama R, Tsuge Y, Shiratori Y, Onozuka M, Moriyama N.

J Magn Reson Imaging. 2008 Apr;27(4):834-9. doi: 10.1002/jmri.21316.

PMID:
18383261
8.

Serial diffusion-weighted MRI in patients with hepatocellular carcinoma: Prediction and assessment of response to transarterial chemoembolization. Preliminary experience.

Mannelli L, Kim S, Hajdu CH, Babb JS, Taouli B.

Eur J Radiol. 2013 Apr;82(4):577-82. doi: 10.1016/j.ejrad.2012.11.026. Epub 2012 Dec 14.

PMID:
23246330
9.

Evaluation of treatment response of chemoembolization in hepatocellular carcinoma with diffusion-weighted imaging on 3.0-T MR imaging.

Sahin H, Harman M, Cinar C, Bozkaya H, Parildar M, Elmas N.

J Vasc Interv Radiol. 2012 Feb;23(2):241-7. doi: 10.1016/j.jvir.2011.08.030. Epub 2011 Oct 22.

PMID:
22019180
10.

Interobserver agreement of semi-automated and manual measurements of functional MRI metrics of treatment response in hepatocellular carcinoma.

Bonekamp D, Bonekamp S, Halappa VG, Geschwind JF, Eng J, Corona-Villalobos CP, Pawlik TM, Kamel IR.

Eur J Radiol. 2014 Mar;83(3):487-96. doi: 10.1016/j.ejrad.2013.11.016. Epub 2013 Dec 3.

11.

Chemoembolization for hepatocellular carcinoma: 1-month response determined with apparent diffusion coefficient is an independent predictor of outcome.

Vandecaveye V, Michielsen K, De Keyzer F, Laleman W, Komuta M, Op de beeck K, Roskams T, Nevens F, Verslype C, Maleux G.

Radiology. 2014 Mar;270(3):747-57. doi: 10.1148/radiol.13130591. Epub 2013 Dec 12.

PMID:
24475816
12.

Contribution of diffusion-weighted magnetic resonance imaging in the characterization of hepatocellular carcinomas and dysplastic nodules in cirrhotic liver.

Xu PJ, Yan FH, Wang JH, Shan Y, Ji Y, Chen CZ.

J Comput Assist Tomogr. 2010 Jul;34(4):506-12. doi: 10.1097/RCT.0b013e3181da3671.

PMID:
20657216
13.

Unresectable hepatocellular carcinoma: serial early vascular and cellular changes after transarterial chemoembolization as detected with MR imaging.

Kamel IR, Liapi E, Reyes DK, Zahurak M, Bluemke DA, Geschwind JF.

Radiology. 2009 Feb;250(2):466-73. doi: 10.1148/radiol.2502072222.

PMID:
19188315
14.

Unresectable hepatocellular carcinoma: MR imaging after intraarterial therapy. Part I. Identification and validation of volumetric functional response criteria.

Bonekamp S, Li Z, Geschwind JF, Halappa VG, Corona-Villalobos CP, Reyes D, Pawlik TM, Bonekamp D, Eng J, Kamel IR.

Radiology. 2013 Aug;268(2):420-30. doi: 10.1148/radiol.13122307. Epub 2013 Apr 24.

15.

Neuroendocrine liver metastasis treated by using intraarterial therapy: volumetric functional imaging biomarkers of early tumor response and survival.

Gowdra Halappa V, Corona-Villalobos CP, Bonekamp S, Li Z, Reyes D, Cosgrove D, Pawlik TM, Diaz LA, Bhagat N, Eng J, Geschwind JF, Kamel IR.

Radiology. 2013 Feb;266(2):502-13. doi: 10.1148/radiol.12120495. Epub 2012 Nov 28.

16.

Role of diffusion-weighted imaging in evaluating therapeutic efficacy after transcatheter arterial chemoembolization for hepatocellular carcinoma.

Kubota K, Yamanishi T, Itoh S, Murata Y, Miyatake K, Yasunami H, Morio K, Hamada N, Nishioka A, Ogawa Y.

Oncol Rep. 2010 Sep;24(3):727-32.

PMID:
20664980
17.

Intrahepatic cholangiocarcinoma treated with local-regional therapy: quantitative volumetric apparent diffusion coefficient maps for assessment of tumor response.

Halappa VG, Bonekamp S, Corona-Villalobos CP, Li Z, Mensa M, Reyes D, Eng J, Bhagat N, Pawlik TM, Geschwind JF, Kamel IR.

Radiology. 2012 Jul;264(1):285-94. doi: 10.1148/radiol.12112142. Epub 2012 May 24.

PMID:
22627601
18.

Renal lesions: characterization with diffusion-weighted imaging versus contrast-enhanced MR imaging.

Taouli B, Thakur RK, Mannelli L, Babb JS, Kim S, Hecht EM, Lee VS, Israel GM.

Radiology. 2009 May;251(2):398-407. doi: 10.1148/radiol.2512080880. Epub 2009 Mar 10.

PMID:
19276322
19.

Small hepatocellular carcinomas: improved sensitivity by combining gadoxetic acid-enhanced and diffusion-weighted MR imaging patterns.

Park MJ, Kim YK, Lee MW, Lee WJ, Kim YS, Kim SH, Choi D, Rhim H.

Radiology. 2012 Sep;264(3):761-70. doi: 10.1148/radiol.12112517. Epub 2012 Jul 27.

PMID:
22843769
20.

High-b-value diffusion-weighted MR imaging of benign hepatocellular lesions: quantitative and qualitative analysis.

Agnello F, Ronot M, Valla DC, Sinkus R, Van Beers BE, Vilgrain V.

Radiology. 2012 Feb;262(2):511-9. doi: 10.1148/radiol.11110922. Epub 2011 Dec 5.

PMID:
22143926
Items per page

Supplemental Content

Write to the Help Desk